The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

By sjmartinez • March 25, 2025

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar;7(3):e70012. doi: 10.1002/acr2.70012. PMID: 40126890.

Tags: General Internal Medicine, Publications, Rheumatology, Veterans Administration

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Mechanisms of Benefit in Geriatric Assessment (GA): Approach-Oriented Coping Mediates Outcomes of a GA-Guided Supportive Care Intervention (GAIN-S)

Bergerot CD, Bergerot PG, Razavi M, França MVDS, Cerveira JA, Fuzita WH, Philip EJ, Ferreira CGM, Buso MM, Nipp R, El-Jawahri A, Soto-Perez-de-Celis E, Dale[...]

A Cluster Randomized Controlled Trial to Improve Influenza and Tdap Vaccination Rates for Pregnant Women

Rand CM, Bender R, Albertin C, Schrader ARB, Humiston SG, Olson-Chen C, Westen EA, Chen J, Hsu YJ, Parker Fiebelkorn A, Vangala S, Szilagyi PG.[...]